Navigation Links
Cell Therapeutics Announces Receipt of NASDAQ Panel Decision to Transfer to NASDAQ Capital Market
Date:1/6/2009

SEATTLE, Jan. 7 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that it has received notification that the NASDAQ Listing Qualifications Panel has granted CTI's request to transfer the listing of its common stock from The NASDAQ Global Market to The NASDAQ Capital Market, which will be effective with the open of trading on Thursday, January 8, 2009. CTI's shares will continue to trade under the ticker symbol CTIC.

CTI's continued listing on The NASDAQ Capital Market is subject to CTI evidencing compliance with all applicable requirements for continued listing on The NASDAQ Capital Market, including the $35 million market value of listed securities requirement or its alternatives, as set forth in NASDAQ Marketplace Rule 4310(c)(3), by February 12, 2009. The Company expects to comply with all applicable requirements for continued listing on The NASDAQ Capital Market by February 12, 2009; however, there can be no assurance that it will be able to do so.

As disclosed on September 6 and October 10, 2008, CTI was previously notified by NASDAQ regarding its non-compliance with the $50 million market value of listed securities requirement for continued listing on The NASDAQ Global Market. In response, CTI appeared before the NASDAQ Listing Qualifications Panel at a hearing at which it requested the transfer of its listing to The NASDAQ Capital Market pursuant to its plan to evidence compliance with the $35 million market value of listed securities requirement for continued listing on that market.

The NASDAQ Capital Market is one of the three market tier designations for NASDAQ-listed stocks and operates in substantially the same manner as The NASDAQ Global Market. Securities listed on The NASDAQ Capital Market must satisfy all applicable qualification requirements for NASDAQ securities, and companies listed on The NASDAQ Capital Market must meet certai
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Horizon Therapeutics Announces Senior Management Appointments
2. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco
3. Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
4. Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
5. Nile Therapeutics Announces Positive Results from Phase 1b Safety and Pharmacodynamics Study of CD-NP in Patients with Heart Failure
6. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes
7. Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics
8. Webcast Alert: Regulus Therapeutics, Alnylam Pharmaceuticals and Isis Pharmaceuticals Announce New Nature Publication on miR-21 Conference Call
9. FDA Accepts Cell Therapeutics Zevalin sBLA and Grants Priority Review
10. Cell Therapeutics, Inc. (CTI) Zevalin Joint Venture Conference Call to be Webcast with Slides
11. Cell Therapeutics, Inc. (CTI) to Discuss Zevalin Joint Venture with Spectrum Pharmaceuticals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...Nov. 6 Helix BioPharma C...announced that John Docherty, president and chief ... Ford,s 6th annual Investor Summit on November 10,...City. Mr. Docherty will provide an overview of th...-DOS47 and Topical Interferon Alpha-2b. The slide...
(Date:11/6/2009)...ia, November 6 EUCODIS Bioscience,... and marketing enzymes for the,chemical industry a...,agreement with Bio Sidus, the leading biopharmace...reement gives EUCODIS Bioscience exclusive access ...idus, proprietary collection of,psychrophilic bact...
(Date:11/6/2009)...lif., Nov. 6 Calbiotech, Inc. anno...ess Innovative Research (SBIR) Phase I contract by...nd. Under terms of the agreement, Calbiotech will ...iagnosis of Dengue virus. ,, Dengue virus is...r threat to military forces deployed to tropical a...
(Date:11/6/2009)...Nov. 6 Intarcia Therapeutics, Inc.... (DUROS® continuous delivery of exenatide) pr...Ninth Annual Diabetes Technology Meeting in San Fr...cgi-bin/prnh/20050301/SFTU126LOGO ) ,, Contin...50 Lowers Plasma Glucose, HbA1c and Reduces Weight...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5
.... 21 Roche has,advised Maxygen, Inc. (Nasdaq: MA...her clinical development of MAXY-alpha, also known...for the treatment of Hepatitis C and,Hepatitis B v...nary observations from a Phase I trial indicate th...and pharmacokinetic effects of,MAXY-alpha occurred...
...Biopharmaceuticals,Inc. (Nasdaq: KERX ) today ann... Company,s Board of Directors. Mr. Tarnok, 53, a ...the,Keryx Board with extensive pharmaceutical indu...s. Mr. Tarnok spent the majority of his career at,...rector - US,Manufacturing, and from 2000-2007, ser...
...les kiss, a new kind of biosensor can tell., A ne...ped by chemists at Vanderbilt University that can ...labeled biological molecules including proteins, s...y the kind of capability needed to capitalize on t...p by the 15-year-plus effort to sequence the human...
Other Biology Technology:Maxygen Announces Hold on MAXY-alpha Development Program 2Maxygen Announces Hold on MAXY-alpha Development Program 3Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors 2When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell 2When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell 3
(Date:11/9/2009)... , A team of academic, government and industry re...va (Manihot esculenta) genome. The project is an i...search on this subsistence crop and addressing som...s around the world. , Cassava is a root crop tha...750 million people each day. Although it has many ...
(Date:11/9/2009)... , PALO ALTO, Calif., Nov. 9 ...nal "Sustainable Energy Award" from the American I...ellerase® family of enzymes for cellulosic et... Awards committee, presented the award to Landon S...and Accellerase® Product Manager, and Aaron K...
(Date:11/9/2009)... , A chemical culprit responsible for the rapid...tlantic Ocean has been found by collaborating scie...eanographic Institution (WHOI). This same chemica..., The team discovered a previously unknown lipid...cking and killing Emiliania huxleyi , a phytoplan...
Breaking Biology News(10 mins):Researchers complete draft genome sequence for cassava 2Researchers complete draft genome sequence for cassava 3Researchers complete draft genome sequence for cassava 4Genencor Wins The American Institute of Chemical Engineers (AIChE) Sustainable Energy Award For Accellerase(R) Cellulosic Ethanol Enzymes 2Newly discovered fat molecule: An undersea killer with an upside 2Newly discovered fat molecule: An undersea killer with an upside 3Newly discovered fat molecule: An undersea killer with an upside 4Nuevolution Announces New Research Collaboration With Big Pharma 55674 1Nuevolution Announces New Research Collaboration With Big Pharma 55674 2The Eye Institute Receives 2009 Best of Rock Springs Award from U S Commerce Association 55672 1The Eye Institute Receives 2009 Best of Rock Springs Award from U S Commerce Association 55672 2The Eye Institute Receives 2009 Best of Rock Springs Award from U S Commerce Association 55672 3Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 1Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 2Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 3Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 4
...blem, arsenic contamination of drinking water does... work by University of Wisconsin-Madison researche... treatment varies depending on the source of the c...cks is usually associated with sulfur- or iron-ric...r, explains lead researcher Madeline Gotkowitz, a ...
...tracted to a male, entire suites of genes in her b...versity of Texas at Austin studying swordtail fish...ome genes were turned on when females found a male...ned off. , When females were most excitedwhen att...down regulation [turning off] of genes, said Cummi...
...nd abrasions in the mouth, also known as sports-re...etes. According to the U.S. Centers for Disease Co...more than 600,000 emergency room visits each year....as a preventive measure. In some 200,000 cases ann...njuries and cut the risk of concussion by 50 perce...
Other Biology News:Arsenic contamination lacks one-size-fits-all remedy 2Arsenic contamination lacks one-size-fits-all remedy 3When she's turned on, some of her genes turn off 2To keep mouths safe, don't just wear a mouthguard; keep it clean 2
...niversal digital valve, just 8 mm in width. The X...features in a single glass-reinforced, PBT (Polybu...ct size; only 8mm in width. , Meets a range of pre..., Satisfies a 0.016 sccm leakage specification (0....
...designed to save time and provide contamination-fr...nating the recycling and resterilizing necessary w...y packaged, RNase/DNase free, non-pyrogenic and an...t number, created to easily match Cornings product...
...f cells • Blade design minimizes cell damage ...bull; Designed for use in 25 and 75cm flasks &bull...radiation and certified nonpyrogenic Linkage: This...sily match Cornings product number. If showing no ...
...ent based screening project: , 384 Individua...xtures of 4 (5 uL each) , PDB and dictionary ...ompounds are dissolved in DMSO at ca. 200 mM, mixt... trays. Dilute library with protein crystallizat...
Biology Products: